Nachrichten zur Acadia Pharmaceuticals Inc. Aktie

Acadia Pharmaceuticals: Reeling After PWS Failure - Downgrading To Hold

…

Ionis Pharmaceuticals Aktienanalyse: Tryngolza und Dawnzera starten durch - Raymond James passt Kursziel an!

Bad Marienberg (www.aktiencheck.de)???? Ionis Pharmaceuticals begeistert Analysten: Raymond James hebt Kursziel auf 75 USD - "strong buy"Ionis Pharmaceuticals Inc. (ISIN:…

Kaufalarm bei Acadia Pharmaceuticals (ACAD): Innovationsführer in der Neurotherapie mit starkem Wachstumspotenzial!

Acadia Pharmaceuticals (ACAD) widmet sich insbesondere der Behandlung von Parkinson-Psychose, dem Rett-Syndrom und der Alzheimer-Psychose. Die Parkinson-Psychose (PDP) betrifft etwa…

Acadia Pharmaceuticals: Another Legal Win, ACP-101 Readout Preview

…

NRx Pharmaceuticals, Inc. (NRXP) Q1 2025 Earnings Call Transcript

…

Acadia Pharmaceuticals shares surge on patent ruling By Investing.com

Acadia Pharmaceuticals shares surge on patent ruling…

Adial Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

GLEN ALLEN, Va., May 15, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”),…

Acadia Pharmaceuticals (ACAD) Tops Q1 Earnings and Revenue Estimates (Revised)

Acadia (ACAD) delivered earnings and revenue surprises of 10% and 1.23%, respectively, for the quarter ended March 2025. Do the…

Adial Pharmaceuticals Announces a Warrant Inducement Transaction for $2.75 Million in Gross Proceeds

GLEN ALLEN, Va., May 02, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”),…

NRx Pharmaceuticals, Inc. (NRXP) Q4 2024 Earnings Call Transcript

…

Adial Pharmaceuticals Reports 2024 Fiscal Year Financial Results and Provides Business Update

GLEN ALLEN, Va., March 04, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”),…

BioStock: Saniona strengthened its cash position and advanced through partnership

Saniona’s key milestone in 2024 was securing an exclusive worldwide licensing agreement with Acadia Pharmaceuticals worth up to USD 610…

Acadia Pharmaceuticals (ACAD) Q4 Earnings Lag Estimates

Acadia (ACAD) delivered earnings and revenue surprises of -10.53% and 1.79%, respectively, for the quarter ended December 2024. Do the…

BioStock: Saniona’s CEO responds to investors’ questions

Saniona’s collaboration with Acadia Pharmaceuticals, signed in November, marked a significant milestone for the company. With a total potential value…